sars-banner.jpg

SARS-COV-2 MPRO Inhibitors With Antiviral Activity In A Transgenic Mouse Model

A recent breakthrough paper in Science Magazine discusses possible new therapeutics for SARS-CoV-2 using our humanized ACE2 models for COVID research. Please contact us to find out more about the hACE2 model at sales@gempharmatech.us.

Read the full article at: science.sciencemag.org

Download the supplemental materials.